SCHEMBL29133792

SCHEMBL29133792

CC1(C)OB(c2ccc3ncc(C#N)c(NCCc4ccccc4)c3c2)OC1(C)C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDPK1 O15530 1/20 0.42
CCNC P24863 2/20 0.41
CDK8 P49336 2/20 0.41
CDKN1A P38936 1/20 0.41
CDK19 Q9BWU1 1/20 0.41
MAP3K8 P41279 3/20 0.41
MAP2K1 Q02750 5/20 0.39
TP53 P04637 1/20 0.39
MAPT P10636 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SRC P12931 4/20 0.39
MAPK13 O15264 1/20 0.39
MAPK12 P53778 1/20 0.39
MAPK11 Q15759 1/20 0.39
MAPK14 Q16539 1/20 0.39
RAF1 P04049 1/20 0.39
EGFR P00533 5/20 0.38
LRRK2 Q5S007 1/20 0.37
PRKDC P78527 2/20 0.37
ABL1 P00519 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24576517 0.80 EGFR (0.60) MAP3K8MAP2K1RAF1EGFRLRRK2
SCHEMBL29775060 0.80 EGFR (0.60) MAP3K8MAP2K1RAF1EGFRLRRK2
SCHEMBL29775065 0.80 EGFR (0.60) MAP3K8MAP2K1RAF1EGFRLRRK2
SCHEMBL29133766 0.78 CCNC (0.57) PDPK1CCNCCDK8CDKN1ACDK19
SCHEMBL29133695 0.78 HTT (0.57) CCNCCDK8CDKN1ACDK19SMN1; SMN2
SCHEMBL29133710 0.75 CYP1A2 (0.52) CCNCCDK8CDKN1ACDK19MAPT
SCHEMBL29133731 0.74 EGFR (0.63) PDPK1CCNCCDK8CDKN1ACDK19
SCHEMBL29133717 0.73 EGFR (0.50) PDPK1CCNCCDK8CDKN1ACDK19
SCHEMBL29133738 0.73 CCNC (0.47) PDPK1CCNCCDK8CDKN1ACDK19
SCHEMBL29133761 0.73 EGFR (0.51) PDPK1CCNCCDK8CDKN1ACDK19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117295716-A Substituted aminobenzyl heteroaryl compounds as EGFR and/or PI3K inhibitors 麦克尼斯迪克治疗有限公司 2023-12-26 CN disclosed